leadf
logo-loader
viewOncoSil Medical Ltd

OncoSil Medical with Proactive at ASX Small and Mid-Cap Conference

OncoSil Medical Ltd (ASX:OSL) chief executive officer Daniel Kenny speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. 

The medical device company is seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSil™ is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound.

Quick facts: OncoSil Medical Ltd

Price: 0.14 AUD

ASX:OSL
Market: ASX
Market Cap: $116 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Galena Mining 'astounded' with best-ever high-grade lead-silver drill result...

Galena Mining Ltd's (ASX:G1A) (FRA:GM6) Alex Molyneux caught up with Proactive's Andrew Scott soon after reporting that they've hit the best-ever high-grade lead-silver drill result at the Abra Base Metals Project. Hole AB147 returned up to 17.1% lead and 34 g/t silver. The company's also...

26 minutes ago

2 min read